Skip to main content
Fig. 5 | Bioelectronic Medicine

Fig. 5

From: Exploring the efficacy of Transcutaneous Auricular Vagus nerve stimulation (taVNS) in modulating local and systemic inflammation in experimental models of colitis

Fig. 5

Non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) decreases the colonic expression levels of pro-apoptotic markers in non-colitic and colitic mice and increases the expression level of the pro-survival marker Bad in non-colitic mice. taVNS (with stimulation parameters of 10 volts, a 500 µs pulse width, 30 s on/off duration, 10 min stimulation duration, and a frequency of 20 Hz) and no stimulation (anesthesia without any stimulation) were performed for the taVNS and CTRL (no stimulation) groups, respectively, beginning one day before the induction of acute colitis and continued daily until the mice were sacrificed. After 24 h, acute colitis was induced in the colitis (dextran sulfate sodium (DSS)) groups by adding 5% DSS to their drinking water for five days, while control groups continued to receive regular water. Colonic mRNA levels of the pro-apoptotic markers Bcl-2-associated protein x (Bax) (A), BCL2 antagonist/killer 1 (Bak1) (B), and caspase 8 (casp8) (C) and the pro-survival marker BCL2 associated agonist of cell death (Bad) (D). One-way ANOVA and multiple parametric comparison tests (Bonferroni and Šídák) were used to calculate P values. The significance level was set at p < 0.05. n = 5–8 mice/group. Each value is presented as the mean ± SD. This experiment was repeated at least four times

Back to article page